ATG5 and osteosarcoma: In this study, we demonstrated that anlotinib can induce protective autophagy in osteosarcoma cells and that the autophagy induced by anlotinib can facilitate EMT and regulate cytoskeletal rearrangement through ATG5, through which anlotinib-induced autophagy promotes the metastasis of human osteosarcoma cells (Figure 7).